Your search returned 3 results.

Results
	1.	Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. [electronic resource] by Filppula, A M Laitila, J Neuvonen, P J Backman, J T Producer: 20120727 In: British journal of pharmacology vol. 165 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite. [electronic resource] by Filppula, A M Tornio, A Niemi, M Neuvonen, P J Backman, J T Producer: 20131216 In: Clinical pharmacology and therapeutics vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions. [electronic resource] by Tornio, A Filppula, A M Kailari, O Neuvonen, M Nyrönen, T H Tapaninen, T Neuvonen, P J Niemi, M Backman, J T Producer: 20141124 In: Clinical pharmacology and therapeutics vol. 96 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search